Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Vantage Consulting Group Paves Way for Drug Manufacturers to Implement and Demonstrate GS1 EPCIS 1.2 Compliance for FDA's DSCSA Track and Trace Requirements

QU4RTET 3.0 is the first Level 4 Serialization Solution to earn Drummond Certification per GS1 EPCIS 1.2 Conformance Program.


News provided by

Drummond Group

Mar 05, 2020, 08:00 ET

Share this article

Share toX

Share this article

Share toX


PORTSMOUTH, N.H., March 5, 2020 /PRNewswire-PRWeb/ -- Drummond Group, the trusted leader in software compliance and interoperability testing, announced Vantage Consulting Group selected Drummond for the validation and certification of the Level-4 open source solution QU4RTET 3.0 in accordance to GS1 US Rx EPCIS Conformance Testing Program.

Drummond is pleased to announce that QU4RTET 3.0 has earned Drummond's EPCIS 1.2 Certification seal. Vantage can now engage with their clients for implementation of QU4RTET so that these manufacturers can then earn their GS1 EPCIS 1.2 Trustmark's for the Manufacturer Test Scenarios.

Drummond is pleased to announce that QU4RTET 3.0 has earned Drummond’s EPCIS 1.2 Certification seal. Vantage can now engage with their clients for implementation of QU4RTET so that these manufacturers can then earn their GS1 EPCIS 1.2 Trustmark’s for the Manufacturer Test Scenarios.

Post this

With GS1 US overseeing the program, Drummond validated QU4RTET's compliance to all seven manufacturer role-based test scenarios as defined by GS1 EPCIS 1.2 Implementation Guidelines.

Vantage is taking a leadership role in ensuring EPCIS 1.2 messages between the manufacturer and the wholesaler are following the proper format and structure to support DSCSA track and trace requirements. Vantage recognizes the following advantages in bringing QU4RTET into compliance, the first L4 Software Solution to be validated and certified by Drummond for EPCIS 1.2.

  • It is essential to demonstrate compliance to the FDA's Drug Supply Chain Security Act (DSCSA) for traceability in the supply chain
  • Earning the Drummond EPCIS 1.2 Certification seal is the first step in demonstrating compliance to DSCSA interoperability requirements for serialization. It is very important to us as a QU4RTET integration provider to ensure our customers can implement a GS1 EPCIS 1.2 certified solution so that they can earn their GS1 Trustmark for their implementation of QU4RTET 3.0

"Drummond's rigorous yet intuitive EPCIS Conformance Portal, a web-based compliance testing service, was key to providing us with a straightforward way to demonstrate QU4RTET compliance to GS1 EPCIS 1.2 Implementation Guidelines. This provides assurance to our customers that Vantage is committed to guiding pharmaceutical manufacturers toward meeting DSCSA track and trace requirements" said George Poltorak, Vantage Consulting Group CEO.

"Drummond was the first testing service to be certified by GS1 and we are pleased to announce QU4RTET 3.0 has been conformance validated against GS1 EPCIS 1.2 Implementation Guidelines, which define how GS1 standards can be used to meet DSCSA track and trace requirements in an interoperable way" said Aaron Gomez, Drummond, Principal, Supply Chain Security business unit.

Further, Drummond is committed to the GS1 EPCIS Conformance Program and we welcome any stakeholder in the pharmaceutical supply chain impacted by FDA's DSCSA mandate to contact Drummond to learn more about this testing service and for inquires to discuss how to gain trial access and a request demonstration.

------------------------------------------------------------------------

About Drummond
Drummond offers a comprehensive suite of services (including GS1 GDSN Data Pool Certification Testing), to help you achieve compliance with regulatory information security mandates and ensure critical business applications meet interoperability and application conformance. Increase trust, gain expertise and experience our proven methodologies and attention to detail as we partner with you for your long-term success. For more information visit: drummondgroup.com

About Vantage Consulting Group
Vantage is the manufacturing productivity company. For manufacturers facing safety, quality, or efficiency challenges, we provide strategic guidance and cost-effective execution of initiatives to improve serialization, packaging, inspection and more. Our team is seasoned, lean, on time and within your budget. vantage-cg.com.

About QU4RTET
QU4RTET is a collaborative track and trace software and an open-source platform. The code is perpetually open source once released and, thus, public domain.

QU4RTET proudly boasts historic support by capital investors and is bolstered by developer time and resources. The open-source code has been collectively created by experienced developers with decades of industry knowledge. QU4RTET supports EPCIS 1.2. qu4rtet.com/about/

SOURCE Drummond Group

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.